Apolipoprotein E4 Allele in Subjects with COVID-19


HUBACEK Jaroslav Alois DLOUHA Lucie DUŠEK Ladislav MÁJEK Ondřej ADAMKOVA Vera

Year of publication 2021
Type Article in Periodical
Magazine / Source GERONTOLOGY
MU Faculty or unit

Faculty of Medicine

Web https://www.karger.com/Article/Pdf/516200
Doi http://dx.doi.org/10.1159/000516200
Keywords COVID-19; Apolipoprotein E4 Allele
Description We recently read with keen interest a study by Del Ser et al., who suggest that carriers of APOE4 alleles come under increased risk of mild to moderate symptoms of coronavirus disease 2019 (COVID-19) during SARSCoV-2 infection. COVID-19 disease occurs as a consequence of infection with the RNA coronavirus SARSCoV-2. First reported in Wuhan, China, in December 2019, COVID-19 has since spread rapidly and has become a global pandemic. Although highly contagious, the virus is nonetheless associated with relatively low mortality when compared with other coronavirus infections (MERS or SARS).

You are running an old browser version. We recommend updating your browser to its latest version.

More info